Nursing · Independent exam preparation

Certified Registered Nurse Infusion (CRNI®) Examination Study Guide

Practise vascular access selection, infection prevention, infusion monitoring, and complication decisions with 60 focused CRNI concepts and original practice drills.

By CertMedbry · Updated 28 October 2026

60 concepts explainedWorked examples & common pitfallsOfficial blueprint references

Practise choosing appropriate access, protecting asepsis, checking delivery, and distinguishing device complications from systemic treatment reactions. These 60 selective concepts connect clinical cues to nursing decisions across the three CRNI® domains. Use the official September 2025 Exam Content Outline as the full scope, including equipment, access routes, special populations, and therapies that need further study beyond this guide.

Try 20 free practice questions

What is the exam format?

Check the question types, timing and outline before planning your revision.

How many questions are on the examination, and how much testing time is available?

The September 2025 outline specifies 140 total items: 120 scored questions plus 20 unscored pretest questions. Testing time is 150 minutes. Prepare to address every item rather than trying to identify which questions are unscored.

Certified Registered Nurse Infusion (CRNI®) Exam Content Outline

Which blueprint applies, and how are its domains weighted?

The official outline effective September 2025 allocates 35 scored questions to Principles of Practice, 39 to Access Devices, and 46 to Infusion Therapies. The issuer's preparation page publishes the corresponding weights as 29%, 33%, and 38%. This guide allocates its 60 concepts as 16, 19, and 25 respectively; both the questions and flashcards allocate 6, 6, and 8.

Certified Registered Nurse Infusion (CRNI®) Exam Content Outline · Prepare for the CRNI® Exam

Why should therapy subsection counts be interpreted cautiously?

The outline states 46 scored Infusion Therapies questions, but its nine listed therapy subsection counts total 49. The major-domain allocation agrees with the preparation page and is used here. The discrepancy remains unresolved; the subsection numbers should not be silently corrected or treated as a consistent detailed weighting.

Certified Registered Nurse Infusion (CRNI®) Exam Content Outline · Prepare for the CRNI® Exam

What question styles and delivery method are described?

The issuer describes four-option multiple-choice questions assessing recall and application. The January 2026 handbook describes computer delivery at PSI Assessment Centers, with questions that can be bookmarked, revisited, and changed within the time limit. These sources do not identify a computer-adaptive format. The 20 questions here are independent single-best-answer drills.

Prepare for the CRNI® Exam · CRNI® Exam Handbook — Revised January 2026

Is there a fixed passing percentage?

The cited outline and handbook do not establish a fixed numerical passing percentage. INCC describes Angoff standard setting for a base form and pre-equating for subsequent forms, whose raw passing points can differ. Performance on this short practice test does not predict certification success.

CRNI® Exam Handbook — Revised January 2026 · Certified Registered Nurse Infusion (CRNI®) Exam Content Outline

Does international eligibility lead to a different clinical examination?

The January 2026 handbook describes domestic and international eligibility arrangements for the same CRNI® examination. It states that the examination reflects United States practices, regulations, and culture and is in English. International eligibility does not establish a separate country-specific blueprint. This is an RN specialty certification rather than a nurse practitioner examination.

CRNI® Exam Handbook — Revised January 2026

Which handbook supports the examination logistics summarized here?

The January 2026 handbook supports the delivery, question-navigation, and scoring details summarized here. It is an earlier handbook and should not be assumed to contain the latest administrative requirements. Confirm current appointment, eligibility, identification, and application requirements with INCC before applying or attending an examination.

CRNI® Exam Handbook — Revised January 2026 · Prepare for the CRNI® Exam

This guide addresses INCC's Certified Registered Nurse Infusion examination, an RN specialty certification reflecting United States infusion nursing practice. The workbook wording “Certified Registered Nurse Infusionist” maps to this same examination. These independently authored learning materials are not endorsed by INCC.

Outline used: Official Exam Content Outline effective September 2025, currently linked from the issuer's preparation page on 2026-10-11. The workbook label 'Certified Registered Nurse Infusionist' maps to the official 'Certified Registered Nurse Infusion (CRNI®)' examination; the assigned slug is preserved.

60 key concepts: understand, apply and avoid the traps

Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.

Principles of Practice29%

1.Why can an open central venous tract admit air?

Air can enter when an open connection or catheter tract communicates with a central vein whose pressure is below atmospheric pressure. Spontaneous inspiration lowers intrathoracic pressure and can increase this gradient. The key hazard is an open venous pathway combined with favorable pressure conditions, not simply a visibly large wound. Preventive decisions therefore address patient position, respiratory timing, and immediate closure of the pathway during central catheter removal.

Apply it

A patient takes a deep breath while a central catheter is being removed in a seated position. Identify the pressure gradient as the concern and prepare a safer removal plan before opening the tract.

Common pitfall: Assuming air entry requires active suction misses the mechanism: atmospheric pressure can drive air inward through an exposed pathway when venous pressure falls.

CVC Removal: A Procedure Like Any Other

2.How does positioning reduce central catheter removal risk?

Supine positioning, or head-down positioning when appropriate and tolerated, helps avoid the low central venous pressure associated with upright removal. A coordinated breath-hold or Valsalva maneuver in a cooperative patient can further reduce air entry during withdrawal. Positioning is one part of the procedure: the tract also needs immediate occlusion and an air-occlusive dressing. A patient unable to tolerate the planned position requires an individualized, coordinated removal approach.

Apply it

A cooperative adult is scheduled for internal jugular catheter removal. Before withdrawing the catheter, the nurse positions the patient appropriately, rehearses the respiratory maneuver, and places the materials for immediate tract occlusion within reach.

Common pitfall: A successful breath-hold does not eliminate the need to seal the tract. Air may enter after catheter withdrawal if the pathway remains open.

CVC Removal: A Procedure Like Any Other

3.When should alcohol hand rub give way to soap and water?

Alcohol-based hand rub is preferred for most routine clinical hand hygiene when hands are not visibly soiled. Soap and water are needed when hands are visibly dirty, as well as in other circumstances identified by infection-control guidance. The practical decision begins with the condition of the hands rather than habit or convenience. Perform hand hygiene before aseptic access work and after patient contact or glove removal to interrupt organism transfer.

Apply it

After removing gloves, a nurse notices visible blood on a finger before preparing another patient's infusion. The nurse washes with soap and water rather than relying only on alcohol hand rub for this episode.

Common pitfall: Choosing alcohol hand rub solely because it is faster overlooks visible contamination. Conversely, requiring soap and water for every routine encounter misstates CDC guidance.

Clinical Safety: Hand Hygiene for Healthcare Workers

4.Why do gloves fail to replace hand hygiene?

Gloves provide a barrier but do not reliably prevent all hand contamination. Hands may become contaminated through defects or during glove removal, and contaminated gloves can carry organisms between tasks. Hand hygiene remains necessary before donning gloves when indicated and after removing them. Change gloves when moving from a contaminated task to a clean task; otherwise, the same barrier that protected the wearer becomes a vehicle for transferring organisms.

Apply it

A nurse empties a drainage container while wearing gloves, then reaches toward a vascular access connector. The nurse stops, removes the gloves, performs hand hygiene, and uses appropriate clean supplies before the aseptic task.

Common pitfall: Keeping one pair of gloves on throughout care appears efficient but spreads contamination across tasks. A gloved hand is not automatically a clean hand.

Clinical Safety: Hand Hygiene for Healthcare Workers

5.How should a prepared insertion site be protected from touch?

Skin antisepsis reduces organisms at the puncture site, but subsequent contact can reintroduce contamination. CDC recommends avoiding palpation after antiseptic application unless aseptic technique is maintained. This creates a clear decision boundary: locating the vein before preparation differs from touching the prepared puncture area afterward. If reassessment requires contact, use an approach that preserves asepsis rather than treating the completed skin preparation as permanent protection against later contamination.

Apply it

After preparing a peripheral insertion site, a nurse wants to feel the vein again with a nonsterile fingertip. The nurse recognizes that the intended puncture area must remain protected and restores an aseptic approach.

Common pitfall: An examination glove does not make post-preparation palpation aseptic. The relevant issue is whether contact contaminates the prepared site, not whether a glove is present.

Summary of Recommendations: Intravascular Catheter-Related Infections

6.Why must skin antiseptic dry before catheter insertion?

Antiseptic effectiveness depends on correct application and the manufacturer's required drying time. For central venous and peripheral arterial catheter insertion, CDC recommends a preparation containing more than 0.5% chlorhexidine with alcohol unless contraindicated. Letting the preparation dry is part of the antiseptic process, not an optional pause. Patient factors and product restrictions still matter; selecting chlorhexidine does not justify ignoring age-specific cautions, allergy, or instructions for use.

Apply it

An operator prepares a central insertion site with the selected chlorhexidine-alcohol product and immediately reaches for the needle. The nurse pauses the procedure until the antiseptic has dried according to its instructions.

Common pitfall: Blotting away wet antiseptic to accelerate the procedure can undermine proper application. A product's name alone does not establish that adequate antisepsis has occurred.

Summary of Recommendations: Intravascular Catheter-Related Infections

7.Which barriers belong to central catheter insertion?

Maximal sterile barrier precautions for CVC and PICC insertion include a cap, mask, sterile gown, sterile gloves, and a sterile full-body drape. These barriers reduce opportunities for organisms from personnel and the surrounding field to reach the insertion site or equipment. A small sterile drape and sterile gloves alone do not provide the same protection. PICC insertion remains a central catheter procedure despite the catheter entering through an arm vein.

Apply it

A PICC insertion tray contains sterile gloves and a small fenestrated drape, but the operator has no sterile gown. The nurse obtains the missing maximal barrier components before allowing the insertion to proceed.

Common pitfall: Classifying a PICC by its arm entry site can lead to peripheral insertion precautions. Central tip placement determines why maximal barriers are required here.

Summary of Recommendations: Intravascular Catheter-Related Infections

8.Why do standard precautions apply without a known infection?

Standard precautions respond to the possibility of exposure rather than waiting for a confirmed infectious diagnosis. During vascular access work, hand hygiene, aseptic technique, and protective equipment appropriate to the anticipated exposure interrupt transmission pathways. A negative history does not establish that blood or equipment is harmless. Choose barriers according to the task, such as potential blood contact or splashing, while maintaining aseptic handling of the access system for every patient.

Apply it

A patient reports no infectious illnesses before a blood draw. The nurse still performs hand hygiene and selects protective equipment for anticipated blood exposure rather than using the history to relax routine infection prevention.

Common pitfall: Restricting precautions to patients with known infections misses undiagnosed carriage and exposure risks. Screening information supplements prevention; it does not replace task-based precautions.

Clinical Safety: Hand Hygiene for Healthcare Workers · Summary of Recommendations: Intravascular Catheter-Related Infections

10.When should an unnecessary catheter be removed?

A catheter provides an ongoing route for contamination and device complications even when it is not actively infusing. CDC recommends promptly removing intravascular catheters that are no longer essential. The decision is based on present clinical need rather than convenience, previous difficulty obtaining access, or a vague possibility of future treatment. Daily necessity review converts infection prevention from a dressing-focused activity into an assessment of whether the exposure itself remains justified.

Apply it

An inpatient has completed intravenous therapy and is taking all medications orally, yet a central catheter remains for convenience. The nurse raises removal during the daily review because no current essential indication is identified.

Common pitfall: Keeping access indefinitely “just in case” preserves a complication pathway without a defined benefit. Difficult insertion alone does not establish an ongoing indication.

Summary of Recommendations: Intravascular Catheter-Related Infections

11.Which findings make peripheral phlebitis actionable?

Warmth, tenderness, erythema, and a palpable venous cord are characteristic warning findings of peripheral phlebitis. CDC recommends removing a peripheral catheter when phlebitis, infection, or malfunction develops. A running infusion does not demonstrate that the vein remains suitable, because inflammation may precede complete loss of function. Assess the site and venous course, discontinue the affected catheter, and reassess the need and location for any continuing therapy rather than merely slowing delivery.

Apply it

A peripheral antibiotic infusion is flowing, but the patient reports tenderness and the nurse finds erythema along the vein. The nurse removes the affected catheter and arranges appropriate access for the remaining treatment.

Common pitfall: Treating continued flow as proof of safety delays recognition of vein injury. A patent catheter can still sit in an inflamed or infected vein.

Summary of Recommendations: Intravascular Catheter-Related Infections

12.Why does a normal-looking site not exclude bloodstream infection?

The skin exit site and the bloodstream are different assessment targets. A patient can develop systemic infection without obvious local redness or drainage, so a clean dressing cannot explain away fever or rigors. Conversely, fever alone does not establish that the catheter is the source. CDC advises clinical judgment rather than automatic central catheter removal for fever alone. Integrate symptoms, other potential sources, access assessment, and properly collected diagnostic specimens before attributing causation.

Apply it

A patient with a central catheter develops rigors while the exit site remains dry and unremarkable. The nurse promptly initiates clinical assessment and ordered diagnostic collection instead of dismissing infection because the skin appears normal.

Common pitfall: Both extremes are unsafe reasoning: normal skin does not rule out bloodstream infection, and fever does not independently prove that a central catheter caused it.

Summary of Recommendations: Intravascular Catheter-Related Infections

13.How does identification protect blood culture interpretation?

Blood culture results guide treatment only if the specimen is linked to the correct patient and accurately labeled collection details. CDC's collection guidance emphasizes identifying the patient and documenting specimens correctly. Confirm identity before collection, then label specimens with the required collection information. A technically sterile sample from the wrong patient is still a serious diagnostic error, and missing collection-site information can weaken interpretation when clinicians compare possible sources of bloodstream infection.

Apply it

Two patients require blood cultures on the same unit. Before each draw, the nurse verifies the patient's identifiers and labels the collected bottles for that patient, preserving the collection site and time information.

Common pitfall: Relying on room location or prelabeling unattended bottles creates identification risk. Laboratory accuracy cannot compensate for a specimen assigned to the wrong patient.

Collect Adult Blood Culture Sets

14.Why does adult blood culture volume matter?

The concentration of organisms in blood may be low, so the amount of blood cultured strongly influences the chance of detection. Underfilled adult bottles can reduce diagnostic yield even when collection is aseptic. CDC emphasizes collecting the recommended blood volume and following the blood culture system's instructions. Assess actual filling rather than assuming that obtaining any blood is sufficient; volume adequacy and contamination prevention address different causes of misleading or unhelpful results.

Apply it

An adult culture bottle contains much less blood than the collection system recommends. The nurse identifies this as a diagnostic-yield problem and follows the collection process to obtain an adequate specimen without compromising asepsis.

Common pitfall: Calling a minimally filled bottle adequate because it reached the laboratory confuses specimen receipt with sensitivity. An uncontaminated sample can still be diagnostically insufficient.

Collect Adult Blood Culture Sets

15.How do separate blood culture sets improve interpretation?

Multiple appropriately collected blood culture sets improve organism detection and help distinguish true bacteremia from contamination. A set is a defined collection using the bottles required by the system; several bottles filled from one collection are not equivalent to independent collections. CDC recommends at least two adult sets when bloodstream infection is suspected. Interpret the pattern of growth alongside organism identity and clinical findings rather than treating every positive bottle as equally conclusive.

Apply it

An adult with suspected bloodstream infection has only one set collected. The nurse recognizes the need for the additional indicated set from a separate collection rather than simply adding another bottle to the first draw.

Common pitfall: Counting bottles instead of independent collections can create false confidence. Several bottles from one contaminated collection do not provide the same corroboration as separate sets.

Collect Adult Blood Culture Sets

16.Which surfaces need preparation before blood culture collection?

Blood culture contamination can arise from the patient's skin or from a bottle's access surface. CDC collection guidance therefore addresses both skin antisepsis and disinfection of bottle septa. A newly opened bottle cap does not establish that its septum is sterile. Allow antiseptics to dry as directed and preserve the prepared surfaces from subsequent contamination. These steps reduce introduced organisms that could otherwise trigger unnecessary treatment or obscure the patient's actual bloodstream infection status.

Apply it

A collector prepares the patient's skin but plans to inoculate bottles immediately after removing their caps. The nurse disinfects the bottle septa and allows the required drying before inoculation to address the second contamination route.

Common pitfall: Excellent skin preparation does not correct an unprepared bottle septum. Contamination prevention must follow the entire specimen pathway rather than only the venipuncture site.

Collect Adult Blood Culture Sets

17.How does therapeutic phlebotomy lower iron stores?

In hemochromatosis, removing blood removes iron contained in red cells. Replacement red-cell production then draws on stored iron, gradually reducing excess stores. NIDDK describes iron monitoring and adjustment of treatment as stores fall. The AASLD 2011 guideline separately recommends checking hemoglobin or hematocrit before each phlebotomy and avoiding a fall below 80% of the starting value. Iron burden guides depletion and maintenance, while hematologic tolerance helps determine whether the next collection is appropriate.

Apply it

A patient receiving phlebotomy has improving iron measures but a substantial hemoglobin decline. The nurse checks the preprocedure hemoglobin or hematocrit and raises the trend for reassessment before another collection.

Common pitfall: Ferritin monitoring and hemoglobin monitoring answer different questions. Continued iron overload does not establish that another blood removal is currently tolerated.

Treatment of Hemochromatosis · Diagnosis%20and%20Management%20of%20Hemochromatosis%202011.pdf

Access Devices33%

18.What makes a midline a peripheral device?

A midline enters an upper-arm vein but its tip remains in the peripheral venous system rather than reaching central circulation. Catheter length or upper-arm placement does not confer central access characteristics. Therapy selection must therefore respect peripheral compatibility even when the device appears substantial or can remain useful longer than a short cannula. Distinguish device identity by tip location and intended use, not by the appearance of external tubing or the insertion location alone.

Apply it

A patient with a midline is prescribed a solution that requires central venous administration. The nurse identifies the mismatch and obtains an appropriate access plan instead of assuming an upper-arm catheter provides central dilution.

Common pitfall: Calling every long arm catheter a PICC creates a dangerous classification error. A midline remains peripheral despite its length and deeper vein placement.

VA Midline Insertion · What Is Parenteral Nutrition? — ASPEN

19.How should central catheter identity be established?

A PICC has a peripheral insertion site but a central tip; a tunneled central catheter has a subcutaneous tunnel before venous entry. These labels describe different features and do not independently prove that a device is currently safe to use. Establish the documented device type, intended tip position, external condition, and evidence of displacement before administration. An arm entry site does not make a PICC peripheral, and a tunnel does not eliminate central line maintenance requirements.

Apply it

A handover describes an arm catheter as “probably a midline.” Before administering a central-only infusion, the nurse checks the device record and placement information rather than assigning the access type from its external appearance.

Common pitfall: Guessing access type from the visible exit site can misclassify both therapy suitability and maintenance needs. Uncertain identity must be resolved before device-dependent administration.

Summary of Recommendations: Intravascular Catheter-Related Infections · Caring For Your Tunnelled Central Venous Catheter

20.Why should catheter lumens match actual treatment needs?

CDC recommends using a CVC with the minimum number of ports or lumens essential for managing the patient. Additional lumens create more access points and handling opportunities without necessarily improving care. Device planning should begin with the therapies that must run, their compatibility, and expected access requirements. The goal is sufficient capability with justified complexity, rather than selecting the largest or most elaborate device because it might be convenient for an unspecified future treatment.

Apply it

A patient needs one continuous infusion and no identified simultaneous incompatible therapy. The nurse questions a proposed multilumen central catheter and asks whether a simpler device can meet the documented treatment requirements safely.

Common pitfall: More lumens do not automatically mean better access planning. Unused capacity can add manipulation opportunities while providing no current therapeutic benefit to the patient.

Summary of Recommendations: Intravascular Catheter-Related Infections

21.How should pump programming be verified?

Pump safety requires agreement between the prescription, actual solution concentration, selected programming units, and intended delivery rate. FDA recommends checking settings and using independent checks for high-risk infusions according to the clinical process. A dose-error reduction library can help detect some mistakes, but its protection depends on the correct drug, concentration, and care profile being selected. Verification must therefore compare the complete setup with the order rather than merely confirming that the pump accepted an entry.

Apply it

A pump displays the correct drug name, but its selected concentration differs from the bag label. The nurse resolves the concentration mismatch before starting therapy instead of relying on the absence of a limit alert.

Common pitfall: An accepted pump setting is not proof of a correct prescription match. A wrong library selection may make an erroneous entry appear internally consistent.

Infusion Pump Risk Reduction Strategies for Clinicians

22.Why must actual infusion delivery be checked separately?

A pump's displayed rate reflects its programmed operation, not independent proof that the patient receives the intended therapy. FDA advises monitoring patients and checking that the expected volume is actually delivered. Examine the fluid container, tubing path, connections, access site, and clinical response when delivery appears inconsistent. Incorrect setup, disconnected tubing, infiltration, or device problems may not be explained by the displayed rate, so bedside assessment remains necessary even when no alarm is sounding.

Apply it

A pump reports normal operation, but a bag has barely emptied during the expected interval. The nurse compares expected and actual volume, traces the line, and assesses the patient instead of documenting delivery from the screen alone.

Common pitfall: Silence from an alarm system does not establish effective treatment. Pump status, actual fluid movement, and the patient's response answer different safety questions.

Infusion Pump Risk Reduction Strategies for Clinicians

23.How do volume and time determine an infusion rate?

For a prescribed volume over a specified time, calculate milliliters per hour by dividing volume in milliliters by time in hours. Convert minutes to hours before division. For gravity delivery, drops per minute equal volume multiplied by the set's drop factor and divided by time in minutes. These calculations describe the ordered delivery; they do not establish whether that order is clinically appropriate. Verify the result against the prescription, equipment, and observed delivery before use.

Apply it

A prescribed 180 mL infusion must run over 90 minutes. Converting 90 minutes to 1.5 hours gives 180 divided by 1.5, or 120 mL/hour, which the nurse checks against the order before programming.

Common pitfall: Dividing milliliters directly by minutes and entering the result as milliliters per hour creates a unit error. Write units throughout the calculation explicitly.

Infusion Pump Risk Reduction Strategies for Clinicians

24.Which equipment checks precede use of a pump system?

The administration set, container, and any required accessories must be compatible with the specific pump and therapy. FDA advises following device instructions and using appropriate administration sets rather than assuming visually similar components are interchangeable. Inspect the setup for damage and verify that tubing is loaded correctly. A filter or add-on component also needs a defined purpose and appropriate specifications; adding equipment without confirming compatibility can create delivery problems instead of providing an automatic safety benefit.

Apply it

A replacement tubing set fits into a pump channel but is not identified as compatible with that model. The nurse obtains the approved set and checks its loading rather than treating physical fit as sufficient verification.

Common pitfall: Interchangeability cannot be inferred from appearance or connector fit. Likewise, a filter does not replace aseptic technique or make every infusate suitable for that setup.

Infusion Pump Risk Reduction Strategies for Clinicians

25.How does ultrasound guidance differ from tip confirmation?

Ultrasound guidance helps identify vessels and guide needle placement during central access insertion. CDC recommends its use, when available, by trained personnel to reduce attempts and mechanical complications. Successful entry into a vein answers a different question from where the catheter tip ultimately lies. Do not treat visualization of needle entry as complete placement verification. Device-specific navigation or confirmation requirements remain relevant before use, particularly when therapy depends on a central rather than peripheral tip.

Apply it

An operator obtains venous access under ultrasound while placing a PICC. The nurse recognizes that successful vessel entry does not by itself document final tip position and checks completion of the device's placement verification process.

Common pitfall: Conflating vein location with final tip location skips a separate placement question. Technology supports trained assessment; its presence alone does not establish readiness for infusion.

Summary of Recommendations: Intravascular Catheter-Related Infections

26.Why does securement protect catheter function?

Securement limits unintended catheter movement and helps preserve the relationship between the external catheter and its intended internal position. CDC recommends sutureless securement to reduce infection risk for intravascular catheters. A dressing and a securement device have related but distinct functions: covering the site does not always provide adequate stabilization. Assess both attachment integrity and evidence of movement. A catheter that appears displaced needs evaluation rather than being pushed back through the skin to restore its previous appearance.

Apply it

A midline's securement has loosened and more catheter is visible externally than previously documented. The nurse protects the device from further movement and arranges assessment instead of advancing the exposed segment back into the arm.

Common pitfall: Adding tape without assessing displacement may hide a significant change. External length changes can signal altered position even when the infusion still appears to flow.

Summary of Recommendations: Intravascular Catheter-Related Infections · VA Midline Insertion

27.When does a catheter dressing need unscheduled replacement?

A dressing should protect the insertion site while allowing appropriate assessment. CDC recommends replacing dressings that become damp, loosened, or visibly soiled rather than waiting for the routine interval. Loss of integrity changes the barrier function immediately, even if the scheduled change date is several days away. Use the appropriate aseptic replacement process and reassess the underlying site. The timing decision follows dressing condition as well as the planned schedule, not the calendar alone.

Apply it

A patient returns from washing with a central catheter dressing wet and lifting at one edge. The nurse replaces it using the appropriate aseptic process now rather than waiting until its scheduled change tomorrow.

Common pitfall: A dated dressing label does not certify continuing barrier integrity. Reinforcing a contaminated or damp dressing can preserve the appearance of coverage without restoring protection.

Summary of Recommendations: Intravascular Catheter-Related Infections

28.How should access be assessed when symptoms are unreliable?

Patients who are sedated, very young, cognitively impaired, or unable to communicate may not report pain that would otherwise reveal a device complication. CDC recommends regular site assessment by inspection and palpation as appropriate to the dressing. The absence of a complaint therefore carries less reassurance in these patients. Use observable findings, device function, and changes from baseline to guide assessment rather than waiting for verbal confirmation that an infusion site hurts.

Apply it

An older adult with cognitive impairment has a peripheral infusion and cannot describe discomfort reliably. The nurse directly assesses the site and surrounding tissue during care instead of accepting a lack of complaints as evidence of safety.

Common pitfall: Equating quiet behavior with a comfortable, intact infusion site disadvantages patients who cannot report symptoms. Monitoring must compensate for limited communication rather than depend on it.

Summary of Recommendations: Intravascular Catheter-Related Infections

29.Why should resistance never be overcome by force?

Unexpected flushing resistance signals a problem that needs assessment; it is not an instruction to generate more pressure. Force may damage the catheter or worsen an unrecognized complication. Tunnelled catheter care guidance explicitly advises against forced flushing. Stop and inspect the external system, clamps, tubing, and catheter condition, then follow an appropriate occlusion assessment process. Restoring patency safely requires understanding the cause, because mechanical obstruction, intraluminal material, and positional problems do not have interchangeable solutions.

Apply it

A tunnelled catheter that flushed easily yesterday now resists a gentle attempt. The nurse stops, checks clamps and visible tubing, and seeks further assessment instead of selecting a smaller syringe to push harder.

Common pitfall: A smaller syringe can generate greater pressure for the same applied force. Apparent success from forceful flushing does not demonstrate that the intervention was safe.

Caring For Your Tunnelled Central Venous Catheter

30.How should mechanical occlusion be separated from other causes?

An occlusion assessment starts with accessible mechanical causes such as a closed clamp, kinked tubing, or an incorrect setup. These findings can explain failed delivery without implying an intraluminal clot. Inspect and trace the system before choosing a cause-specific intervention, while avoiding forceful flushing. If correcting an obvious external problem does not restore expected function, further evaluation is needed. The key reasoning step is matching the intervention to the demonstrated cause rather than treating all resistance alike.

Apply it

A pump alarms for occlusion shortly after a patient transfers to a chair. The nurse traces the line and finds tubing compressed beneath the armrest, corrects that problem, and reassesses delivery and the access site.

Common pitfall: Immediately assuming thrombosis can lead to an unnecessary cause-specific treatment. Finding a kink also does not excuse reassessment of the patient and infusion system afterward.

Infusion Pump Risk Reduction Strategies for Clinicians · Caring For Your Tunnelled Central Venous Catheter

32.Why does advanced kidney disease change access planning?

Patients with advanced kidney disease may need preserved vessels for future dialysis access. CDC recommends avoiding subclavian access in hemodialysis patients and those with advanced kidney disease because of subclavian vein stenosis risk. This makes access planning a longitudinal decision rather than a response only to today's infusion. Coordinate the plan with the relevant team and consider the patient's future vascular requirements instead of applying an infection-focused site preference without modification to renal disease.

Apply it

A patient with advanced chronic kidney disease needs central therapy. When subclavian placement is proposed for infection reduction, the nurse raises the risk of stenosis and future dialysis access loss during the access-planning discussion.

Common pitfall: A site can offer an infection advantage yet be unsuitable for preserving future access. Renal disease changes the trade-off rather than simply adding another risk label.

Summary of Recommendations: Intravascular Catheter-Related Infections

33.How do pediatric antiseptic limits affect device care?

Pediatric skin and product restrictions require explicit attention when selecting antiseptic preparations or dressings. CDC's catheter recommendations identify unresolved safety and efficacy questions for chlorhexidine skin preparation in infants younger than two months and advise against chlorhexidine-impregnated dressings in premature neonates because of serious skin reactions. Distinguish the skin preparation from an impregnated dressing; they are separate products with separate evidence boundaries. Adult recommendations should not be transferred automatically to neonatal care.

Apply it

A premature neonate needs central line care, and an adult chlorhexidine-impregnated dressing is proposed. The nurse identifies the neonatal skin-risk boundary and selects an appropriate neonatal approach rather than copying the adult dressing routine.

Common pitfall: Treating every chlorhexidine product as equivalent obscures differences between preparations and dressings. An adult infection-prevention benefit does not establish neonatal safety for the same product.

Summary of Recommendations: Intravascular Catheter-Related Infections

34.Why is immunocompromise alone insufficient reason for routine central catheter replacement?

Immunocompromise increases the importance of reliable prevention and prompt assessment, but it does not by itself justify routine scheduled replacement of a functioning central catheter. CDC recommends against routinely replacing CVCs or PICCs solely to prevent infection. Each new insertion also creates procedural exposure. Maintain aseptic care, reassess necessity, and evaluate actual signs of complications instead of using the patient's oncology or immune status as an automatic calendar-based indication for replacement.

Apply it

An oncology patient has a functioning PICC without evidence of infection or malfunction. A proposal to replace it weekly solely because the patient is immunocompromised is reconsidered in favor of careful maintenance and ongoing necessity assessment.

Common pitfall: More frequent insertion is not automatically stronger infection prevention. Routine replacement can add procedural risk without addressing the contamination pathways associated with everyday catheter handling.

Summary of Recommendations: Intravascular Catheter-Related Infections

35.How do infiltration and extravasation differ?

Both involve unintended leakage from the vascular pathway into surrounding tissue. Extravasation concerns an agent capable of significant tissue injury, especially a vesicant, whereas nonvesicant leakage is generally described as infiltration. Pain, swelling, leakage, altered flow, or tissue changes require assessment regardless of terminology. Identify the actual infusate because its injury potential determines subsequent management. Neither continued pump operation nor an initially mild appearance excludes evolving tissue injury after leakage has occurred.

Apply it

A patient develops swelling during an infusion. Before choosing a compress or removing the catheter, the nurse stops delivery and identifies the solution's tissue-injury potential so the event follows the correct management pathway.

Common pitfall: Calling every swollen site a harmless infiltration can understate vesicant injury. Severity depends on the agent and exposure, not simply the initial size of swelling.

Extravasation Management — Clinical Procedure

36.Which actions come first in suspected antineoplastic vesicant extravasation?

Stop delivery immediately and send for assistance. Leave the vascular access device in place initially, disconnect the infusion tubing, and attempt aspiration of residual drug through the device with a sterile syringe. Do not flush. These primary actions precede treatment planning. After initial aspiration, remove a peripheral cannula without applying pressure to the affected area except gentle pressure if needed for hemostasis. For central access, retain the catheter or port needle and arrange assessment with the treating team, potentially including a radiological flow study.

Apply it

Burning and swelling develop during a peripheral antineoplastic vesicant infusion. The nurse stops delivery, calls for help, retains the cannula, disconnects the tubing, and attempts aspiration without flushing before peripheral cannula removal and drug-specific treatment.

Common pitfall: Merely preserving an aspiration route is incomplete: attempt aspiration. Immediate removal sacrifices that route, while flushing may force additional vesicant into tissue.

Extravasation Management — Clinical Procedure · ID-1078-Algorithm-extravasation-management.pdf.aspx

37.How do anthracycline and vinca alkaloid extravasation treatments differ?

eviQ pairs DNA-binding anthracyclines such as doxorubicin with cold treatment to localize exposure and a topical DMSO pathway; dexrazoxane within six hours is an alternative anthracycline antidote pathway and should not be combined with DMSO. Vinca alkaloids such as vincristine receive hyaluronidase and warmth to promote dispersion and dilution. These are drug-specific patterns: oxaliplatin also receives warmth, and taxane extravasation treated with hyaluronidase receives no compress. Confirm the exact agent before selecting thermal treatment or an antidote.

Apply it

After the immediate response, a doxorubicin leak prompts the cold-and-antidote pathway, whereas a vincristine leak prompts warmth and hyaluronidase. The nurse documents the injury and arranges follow-up because damage can evolve.

Common pitfall: Cold localization and warm dispersion are different goals. Neither thermal rule applies to every antineoplastic drug, and an antidote choice can change whether a compress is appropriate.

ID-1078-Algorithm-extravasation-management.pdf.aspx · Extravasation Management — Clinical Procedure

Infusion Therapies38%

9.How do fluid compartments change the interpretation of electrolyte results?

Intracellular fluid is inside cells; extracellular fluid includes plasma and interstitial fluid. Potassium is predominantly intracellular, whereas a serum measurement samples the extracellular compartment. A concentration therefore does not directly measure total body stores. Fluid overload can dilute serum electrolytes, and refeeding can lower serum potassium by shifting it into cells. Interpret a result alongside fluid balance, renal handling, and recent nutritional changes to distinguish dilution or redistribution from net electrolyte loss.

Apply it

After nutrition restarts, a depleted patient's serum potassium falls despite no new gastrointestinal loss. The nurse considers an intracellular shift rather than assuming the result measures a new external loss of the same magnitude.

Common pitfall: Treating serum concentration as a direct inventory of total body electrolyte content overlooks compartment shifts and changes in the amount of water surrounding those electrolytes.

Potassium Chloride Injection, Solution, Concentrate — Fresenius Kabi Label · ASPEN Consensus Recommendations for Refeeding Syndrome

31.How should delivery monitoring distinguish maintenance from replacement fluid?

Maintenance fluid supplies expected daily needs when intake is insufficient; replacement addresses an existing deficit or ongoing abnormal losses. A correctly running maintenance pump does not establish that new vomiting or drainage losses are covered. Track actual infused volumes and measured losses separately. Falling weight, declining blood pressure, tachycardia, or reduced urine output can support concern for volume deficit and require clinical reassessment. Verify a revised prescription's solution, volume, and time before changing delivery, and reassess perfusion and congestion afterward.

Apply it

A patient on maintenance fluid develops substantial drain output and falling urine output. The nurse quantifies the loss and verifies actual delivery, then obtains reassessment of replacement needs rather than assuming the maintenance rate covers the additional loss.

Common pitfall: Maintenance, deficit correction, and replacement of ongoing losses have different purposes. Increasing a pump rate without clarifying the intended fluid plan can cause either inadequate replacement or excessive fluid exposure.

Certified Registered Nurse Infusion (CRNI®) Exam Content Outline · Infusion Pump Risk Reduction Strategies for Clinicians · Potassium Chloride Injection, Solution, Concentrate — Fresenius Kabi Label

38.Why must the patient control PCA demand dosing?

Patient-controlled analgesia links a demand dose to the patient's own decision and ability to press the button. Sedation ordinarily reduces the patient's ability to request further doses, providing an important safety feature. A family member pressing for a sleeping patient bypasses that relationship. MSK instructs that only the patient should use the demand button. Persistent pain, excessive sleepiness, or inability to operate the device requires nursing assessment rather than caregiver substitution for patient demand.

Apply it

A spouse offers to press the PCA button while the patient sleeps so pain will not return. The nurse explains that only the patient should press and assesses comfort and sedation before addressing further analgesia needs.

Common pitfall: A lockout interval does not make caregiver activation safe. It limits permitted timing but cannot determine whether a sleeping patient needs or tolerates another dose.

Patient-Controlled Analgesia — Memorial Sloan Kettering Cancer Center

39.When does a diuretic help transfusion-related respiratory distress?

Diuretics promote fluid excretion and can reduce the hydrostatic congestion of transfusion-associated circulatory overload. Hypertension, raised venous pressure, and positive fluid balance support that treatment rationale. Transfusion-related acute lung injury produces pulmonary edema without circulatory overload; Lifeblood advises that diuretics are not beneficial and may worsen TRALI. First stop the transfusion and stabilize the patient, then distinguish the hemodynamic patterns before treating respiratory distress as a reason to remove fluid.

Apply it

Two patients develop hypoxemia after transfusion. One has hypertension and elevated venous pressure; the other has hypotension without overload evidence. The nurse recognizes why a diuretic may fit the first pattern but could worsen the second.

Common pitfall: Pulmonary edema does not automatically mean excess circulating volume. A medication that relieves hydrostatic congestion may be inappropriate for lung injury without overload.

Management of Suspected Transfusion Reactions

40.Why does central access not eliminate antineoplastic leakage risk?

A central device can still malfunction, become displaced, or leak, so central delivery does not eliminate extravasation risk from an antineoplastic agent. New pain, swelling, leakage, or abnormal function during administration requires prompt investigation. eviQ addresses extravasation involving central as well as peripheral access. The important decision is to respond to evidence of abnormal delivery rather than assuming that a central tip guarantees containment of every dose throughout treatment or makes tissue symptoms unrelated.

Apply it

During an antineoplastic infusion through a central device, a patient reports new discomfort and swelling near the access area. The nurse stops delivery and initiates assessment instead of continuing because the treatment uses central access.

Common pitfall: Equating central access with zero extravasation risk can delay recognition of serious leakage. Device suitability at insertion does not guarantee integrity during every later administration.

Extravasation Management — Clinical Procedure

41.What protection does a closed-system transfer device add?

A closed-system transfer device can reduce hazardous drug escape during transfer and administration, but it is a supplemental control rather than a substitute for primary containment. NIOSH places hazardous drug protection within a hierarchy that includes engineering controls, work practices, and appropriate personal protective equipment. A transfer device does not make open preparation on an ordinary counter acceptable. Evaluate the complete task and containment system, because protection depends on how the drug is handled throughout its pathway.

Apply it

A staff member proposes preparing a hazardous drug outside the designated containment area because a closed-system transfer device is available. The nurse retains the required primary engineering controls and uses the transfer device as an additional safeguard.

Common pitfall: Calling a device “closed” does not certify the entire preparation process as contained. Supplemental technology cannot replace the primary controls needed for hazardous drug handling.

Managing Hazardous Drug Exposures: Information for Healthcare Settings

42.How should hazardous drug exposure risk be assessed?

Exposure risk depends on the drug's hazards and the specific task, including preparation, connection, disconnection, spill management, and disposal. NIOSH recommends a facility-specific assessment that considers dosage form, exposure route, work practices, and available controls. Risk does not end when administration finishes; contaminated materials can remain hazardous. Select containment, protective equipment, and waste handling for the actual activity rather than assuming that a sealed commercial container or a completed infusion eliminates occupational exposure opportunities.

Apply it

A hazardous infusion has finished, and a worker prepares to disconnect and discard the tubing without the designated protective equipment. The nurse identifies disconnection and waste handling as exposure tasks requiring the facility's assessed controls.

Common pitfall: Focusing protection only on compounding overlooks exposure during administration and cleanup. The relevant boundary follows hazardous material and contamination, not the moment the pump stops.

Managing Hazardous Drug Exposures: Information for Healthcare Settings

43.Which findings make a rituximab reaction urgent?

Rituximab can cause severe and fatal infusion reactions, particularly during the first infusion. The label identifies findings such as hypotension, bronchospasm, hypoxia, and other cardiopulmonary events. These are not routine discomforts to tolerate while increasing the rate. Stop or interrupt the infusion according to severity and initiate immediate clinical management; subsequent resumption or permanent discontinuation depends on the reaction. Premedication reduces some reactions but does not remove the need for close monitoring and emergency readiness.

Apply it

During a first rituximab infusion, a patient develops wheezing, falling oxygen saturation, and hypotension. The nurse stops delivery and activates immediate clinical management rather than attributing the findings to anxiety or waiting for the scheduled assessment.

Common pitfall: Premedication is not proof against a serious reaction. Restarting automatically after symptoms improve ignores the need to assess severity and determine an appropriate continuation plan.

RITUXAN Prescribing Information

44.Why is hepatitis B screening required before rituximab?

Rituximab can reactivate hepatitis B in patients with current infection or evidence of previous infection, potentially causing fulminant hepatitis, liver failure, and death. The prescribing information requires screening with HBsAg and anti-HBc before treatment. A negative HBsAg alone does not address prior infection risk. Patients with evidence of current or previous infection need expert input on monitoring and antiviral management, and monitoring may continue after treatment because reactivation can be delayed rather than confined to the infusion.

Apply it

A patient scheduled for rituximab has a negative HBsAg result but no anti-HBc result. The nurse identifies incomplete label-specified screening instead of treating the single negative marker as sufficient evidence that reactivation risk is absent.

Common pitfall: Equating no current surface antigen with no hepatitis B history misses patients with prior infection. Screening must address both current infection and previous exposure.

RITUXAN Prescribing Information

45.How should antibiotics be reassessed after cultures return?

Empiric antibiotics respond to an initial clinical probability before complete microbiologic information is available. CDC stewardship guidance supports reassessment when diagnostic findings and the patient's course become clearer. The review asks whether infection remains likely, whether the selected agent targets the organism, and whether broader coverage is still justified. A positive response does not by itself justify continuing every empiric drug. Culture-directed adjustment should preserve effective treatment while reducing unnecessary spectrum, toxicity, and avoidable antibiotic exposure.

Apply it

A patient improves on broad empiric therapy, and cultures identify an organism susceptible to a narrower option. The nurse brings the result to the treatment review so continued breadth is justified or appropriately reduced.

Common pitfall: Keeping all empiric agents because the patient improved confuses initial success with ongoing necessity. Reassessment uses new evidence rather than preserving the original plan automatically.

The Core Elements of Hospital Antibiotic Stewardship Programs

46.Why should antibiotic duration and route remain explicit decisions?

Antibiotic stewardship includes selecting an appropriate duration and reassessing whether intravenous therapy remains necessary. A functioning catheter does not establish a continuing need for intravenous antibiotics, and a discharge plan should not determine duration by convenience alone. CDC supports treatment review, including opportunities for intravenous-to-oral conversion when appropriate. The decision depends on the infection, available agents, clinical response, and ability to receive effective oral therapy rather than an unsupported universal duration for all infections.

Apply it

A recovering patient can take oral medications and is preparing for discharge with a central catheter. The nurse requests review of the antibiotic's route and planned stop date before assuming that outpatient intravenous treatment remains necessary.

Common pitfall: Clinical improvement does not mean every infection can stop treatment immediately. Equally, an established line does not justify continuing intravenous therapy without reviewing indication and duration.

The Core Elements of Hospital Antibiotic Stewardship Programs

47.Which actions start a suspected transfusion reaction response?

Stop the transfusion and assess airway, breathing, circulation, and vital signs when a reaction is suspected. Lifeblood also emphasizes maintaining venous access, checking patient and component identification, and notifying the treating team and transfusion service. Preserve the component and administration materials for the required investigation rather than discarding evidence. Initial stabilization precedes deciding which reaction occurred. Do not restart automatically, because a mild-looking early symptom may precede a more serious reaction requiring a different management pathway.

Apply it

A patient develops rigors and breathlessness shortly after a transfusion begins. The nurse stops the transfusion, performs immediate assessment, maintains appropriate access, and starts the identification and notification process rather than simply reducing the rate.

Common pitfall: Treating symptoms while leaving the component running permits continued exposure. A working intravenous line should be maintained without flushing remaining blood from the implicated set into the patient.

Management of Suspected Transfusion Reactions

48.Which findings support transfusion-associated circulatory overload?

TACO is a transfusion-associated respiratory complication involving circulatory overload and hydrostatic pulmonary edema. New respiratory distress or pulmonary edema during or up to 12 hours after transfusion becomes more suggestive when accompanied by cardiovascular changes, positive fluid balance, or evidence of cardiac strain. Hypertension, elevated venous pressure, and improvement with diuresis support the pattern. Breathlessness alone is insufficient because other transfusion reactions can also cause respiratory compromise and require urgent assessment.

Apply it

After transfusion, a patient develops dyspnea, rising blood pressure, crackles, and a markedly positive fluid balance. The nurse identifies circulatory overload as a leading concern while stopping exposure and obtaining urgent assessment for a transfusion reaction.

Common pitfall: Labeling every transfusion-related respiratory event as TACO ignores competing causes. Use the overload pattern and timing rather than dyspnea as an isolated diagnostic shortcut.

Transfusion-Associated Circulatory Overload

49.Why must concentrated potassium chloride be diluted?

Potassium chloride concentrate is not a ready-to-administer intravenous push medication. The label requires dilution before intravenous use because direct administration can produce lethal cardiac effects. Safety checks must establish the final preparation and controlled delivery, not merely confirm that replacement potassium was prescribed. A pump cannot make an undiluted concentrate appropriate for administration. The decisive distinction is between the concentrated stock product and a correctly prepared infusion intended to deliver potassium at the ordered rate.

Apply it

A vial of potassium chloride concentrate arrives for a replacement order. The nurse verifies that a correctly diluted infusion will be prepared and administered, preventing the stock vial from being treated as an intravenous push dose.

Common pitfall: Programming a slow pump rate does not correct an inappropriate concentrated preparation. Dilution and delivery controls address separate hazards and must both be verified.

Potassium Chloride Injection, Solution, Concentrate — Fresenius Kabi Label

50.How does impaired renal function change potassium safety?

Renal excretion is central to potassium balance, so impaired kidney function can allow administered potassium to accumulate. The potassium chloride label warns about retention and potentially fatal hyperkalemia in conditions with impaired potassium excretion. A previous low concentration does not guarantee continuing replacement is safe when renal function or urine output changes. Review current potassium, renal status, and the treatment plan together, and clarify unexpected deterioration rather than continuing solely from an earlier laboratory value.

Apply it

A patient prescribed potassium replacement develops markedly reduced urine output before the next infusion. The nurse checks current laboratory and renal information and obtains reassessment instead of administering automatically because potassium was low the previous day.

Common pitfall: Using yesterday's potassium result as permanent authorization overlooks changing excretion. Cardiac monitoring does not substitute for deciding whether additional potassium is appropriate in the first place.

Potassium Chloride Injection, Solution, Concentrate — Fresenius Kabi Label

51.How does cumulative fluid exposure reveal overload risk?

Fluid balance reflects all relevant inputs and outputs rather than the rate of one infusion in isolation. Blood components, maintenance fluids, and medication volumes can collectively exceed a patient's capacity to handle fluid. Lifeblood identifies positive fluid balance and cardiac or renal impairment as important TACO-related considerations. Review the cumulative exposure alongside respiratory findings, blood pressure, and other evidence of congestion. A modest individual rate can still contribute to overload when layered onto substantial preceding intake.

Apply it

A patient with cardiac impairment receives maintenance fluid, several medication infusions, and a transfusion. When breathlessness develops, the nurse reviews the combined fluid history rather than judging safety only from the current blood component's hourly rate.

Common pitfall: An acceptable rate for one container does not prove an acceptable overall fluid load. Cumulative balance and patient reserve can change the meaning of that rate.

Transfusion-Associated Circulatory Overload

52.Why can feeding lower phosphate, potassium, and magnesium?

After prolonged inadequate intake, renewed carbohydrate provision increases insulin activity and drives electrolytes into cells as metabolism becomes anabolic. Phosphate, potassium, and magnesium concentrations can fall despite initially acceptable serum results. ASPEN identifies these changes as central to refeeding syndrome. The risk follows the metabolic transition, not simply the intravenous route, so calories from other sources also matter. Recognize recent nutritional deprivation before increasing nutrition and monitor for biochemical changes and associated organ dysfunction afterward.

Apply it

A severely undernourished patient begins nutrition and develops falling phosphate and potassium over the next two days. The nurse recognizes the timing and electrolyte pattern as possible refeeding effects rather than assuming the solution simply lacks enough electrolytes.

Common pitfall: Refeeding syndrome is not limited to parenteral nutrition. Focusing only on the route misses the insulin-driven metabolic response to renewed calories in a depleted patient.

ASPEN Consensus Recommendations for Refeeding Syndrome

53.How do adult ASPEN criteria identify refeeding risk despite normal electrolytes?

ASPEN's adult consensus criteria identify negligible intake for more than seven days as one criterion sufficient for significant risk. Moderate risk requires two criteria; negligible intake for five to six days is one moderate-risk criterion. Other criteria include weight loss, low BMI, electrolyte abnormalities, and loss of fat or muscle. Normal serum concentrations can coexist with depleted body stores. Assess potassium, magnesium, and phosphorus before nutrition; for high-risk patients, ASPEN recommends monitoring every 12 hours for the first three days, with frequency adjusted to clinical status. These are clinical consensus recommendations, not examination rules.

Apply it

An adult has had negligible intake for eight days but normal initial electrolytes. The nurse recognizes a significant-risk criterion and arranges baseline assessment and early serial monitoring rather than using the normal panel to justify unrestricted feeding.

Common pitfall: One moderate-risk criterion does not meet the two-criterion moderate-risk requirement. Conversely, a single significant-risk criterion can identify significant risk even when initial serum results are normal.

ASPEN Consensus Recommendations for Refeeding Syndrome

54.How does ASPEN classify biochemical refeeding changes?

ASPEN proposes classifying refeeding syndrome by a decrease in phosphorus, potassium, or magnesium within five days of reintroducing or substantially increasing calories. A 10%–20% decrease is mild, 20%–30% moderate, and more than 30% severe; severe classification can also involve organ dysfunction from these changes or thiamine deficiency. This is a relative change framework rather than an absolute concentration alone. Apply the timing and clinical context before attributing any electrolyte decline to refeeding syndrome.

Apply it

Phosphorus falls from 4.0 to 2.8 mg/dL within three days of restarting calories. The nurse calculates a 30% decrease and recognizes the moderate biochemical range while also assessing symptoms and other possible explanations for the decline.

Common pitfall: A percentage decrease and an absolute laboratory value answer different questions. ASPEN's framework also requires the nutritional timing; unrelated electrolyte losses should not be relabeled automatically.

ASPEN Consensus Recommendations for Refeeding Syndrome

55.When does parenteral nutrition address a genuine need?

Parenteral nutrition supplies nutrients intravenously when the gastrointestinal route cannot provide adequate nutrition. ASPEN describes its use when the digestive system is not functioning sufficiently or cannot be used effectively. The indication concerns inability to meet nutritional needs through the gut, not merely the convenience of existing intravenous access. Assess the patient's nutritional requirements and gastrointestinal capability together, because the presence of a central catheter does not establish that intravenous nutrition is preferable or necessary.

Apply it

A patient has central access but can use the gastrointestinal tract effectively. The nurse distinguishes having a route available from having an indication for PN and asks how the proposed nutrition plan addresses a documented nutritional limitation.

Common pitfall: A central line is a delivery opportunity, not an indication. Choosing PN solely because access exists bypasses assessment of whether gastrointestinal nutrition can meet needs.

What Is Parenteral Nutrition? — ASPEN

56.What nutritional components does PN provide?

PN formulations can provide carbohydrate, amino acids, lipids, water, electrolytes, vitamins, and trace elements. These components serve different functions: energy provision does not replace protein substrates, and macronutrients do not replace micronutrients. ASPEN describes PN as a tailored nutritional therapy rather than a single standard fluid. Review the prescription as a coordinated nutrient and fluid plan, recognizing that changes in organ function, losses, or metabolic tolerance can alter requirements even when the patient's calorie target is unchanged.

Apply it

A patient receiving intravenous dextrose is described as already receiving complete nutrition. The nurse explains that carbohydrate alone does not supply amino acids, essential fats, vitamins, trace elements, and the other components of an individualized PN prescription.

Common pitfall: Equating calories with complete nutrition obscures protein and micronutrient needs. A solution can provide energy while remaining inadequate as a comprehensive nutritional therapy.

What Is Parenteral Nutrition? — ASPEN

57.How does PN concentration influence access selection?

Concentrated PN solutions require central venous access because peripheral veins may not tolerate their concentration. ASPEN distinguishes central PN from more dilute peripheral approaches. The access decision follows the actual formulation and anticipated nutritional plan, not the generic label “PN.” A midline remains peripheral and cannot supply central dilution. Verify the prescribed formulation's route requirements before administration and arrange a suitable access plan rather than changing the route informally to fit whichever catheter is already available.

Apply it

A concentrated central PN formulation is delivered for a patient whose only device is a midline. The nurse withholds connection and obtains a compatible formulation-and-access plan instead of assuming that any long catheter is adequate.

Common pitfall: The word PN does not establish one universal route, and catheter length does not establish central access. Formulation and documented tip location must agree.

What Is Parenteral Nutrition? — ASPEN · VA Midline Insertion

58.Why does PN still require meticulous catheter infection prevention?

PN depends on repeated access to an intravenous system, so safe nutrition delivery includes maintaining the catheter barrier and minimizing contamination during handling. A correctly composed formulation does not compensate for contaminated connections or a compromised dressing. Apply catheter infection-prevention measures and assess new systemic symptoms rather than judging safety from the bag alone. CDC also advises against routine systemic antimicrobial prophylaxis solely to prevent catheter infection; prevention rests on appropriate insertion, maintenance, and ongoing necessity assessment.

Apply it

A patient receiving PN develops rigors while the bag and pump appear normal. The nurse assesses the patient and catheter-related infection possibilities rather than treating correct formulation and normal pump operation as evidence that the nutrition system is safe.

Common pitfall: Adding prophylactic antibiotics is not a substitute for catheter care. Nutritional benefit does not remove the infection risks associated with vascular access and repeated handling.

Summary of Recommendations: Intravascular Catheter-Related Infections · What Is Parenteral Nutrition? — ASPEN

59.Why does thiamine matter when calories restart?

Thiamine is required for normal carbohydrate metabolism. In a depleted patient, renewed carbohydrate delivery increases demand and can expose deficiency, contributing to neurologic or cardiovascular dysfunction. ASPEN includes thiamine deficiency in its refeeding framework and recommends preventive supplementation for at-risk patients before feeding or dextrose-containing fluids. This is a distinct issue from replacing phosphate, potassium, and magnesium. Consider the nutritional history before carbohydrate delivery rather than waiting for a classic neurologic syndrome to become unmistakable.

Apply it

An undernourished patient is about to receive dextrose-containing support. The nurse identifies the need for the prescribed thiamine prevention plan before carbohydrate delivery rather than assuming electrolyte replacement alone covers the patient's refeeding risks.

Common pitfall: Correcting phosphate does not correct thiamine deficiency. These related refeeding hazards require separate attention, and normal initial electrolytes do not establish adequate vitamin reserves.

ASPEN Consensus Recommendations for Refeeding Syndrome

60.How does tumor lysis differ from an immediate infusion reaction?

Rituximab can cause tumor lysis syndrome, especially with a high tumor burden or many circulating malignant cells. Rapid cell breakdown releases intracellular contents, producing abnormalities such as hyperkalemia, hyperphosphatemia, hyperuricemia, hypocalcemia, and possible acute kidney injury. The label describes onset within 12–24 hours after the first infusion. This laboratory and renal pattern differs from immediate bronchospasm or hypotension during administration, although both require prompt management. Monitoring must therefore extend beyond whether the infusion itself was tolerated.

Apply it

The day after initial rituximab, a patient with bulky disease develops rising potassium, phosphate, uric acid, and creatinine. The nurse recognizes possible tumor lysis and escalates the findings despite an uneventful infusion the previous day.

Common pitfall: An infusion without acute symptoms does not exclude delayed metabolic complications. Treating the new abnormalities as ordinary dietary electrolyte variation misses the tumor-breakdown pattern.

RITUXAN Prescribing Information

What to focus on during revision

The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.

  • Use the published 29% Principles of Practice, 33% Access Devices, and 38% Infusion Therapies weights to distribute study time, then increase time for demonstrated weaknesses.
  • Connect positioning and respiratory pressure to central catheter removal; connect aseptic actions to the contamination pathway they interrupt.
  • Distinguish catheter entry site from tip location, and match the actual formulation to peripheral or central access requirements.
  • Practise the first response and the next discriminating assessment for resistance, displacement, extravasation, transfusion reactions, and biologic reactions.
  • Track concentration, units, volume, and time through every infusion calculation; verify actual delivery independently of the pump display.
  • Distinguish fluid compartments, volume deficit, routine maintenance, and replacement of abnormal losses. Compare diuretic treatment of circulatory overload with respiratory injury without overload.
  • Study potassium safety, PN, and refeeding together while keeping redistribution, total body depletion, renal retention, and nutritional risk criteria distinct.
  • Expand beyond these selective concepts using the full outline, especially subcutaneous and intraosseous access, ports, filters, solution containers, additional cardiovascular therapies, and population-specific care.

A practical preparation plan

1. Map the full clinical scope

Turn each official outline subsection into a study target. Mark topics you rarely encounter in your practice, including pediatric, renal, oncology, and alternative access situations. Keep administrative information separate from clinical study.

2. Learn decisions through mechanisms

For each concept, explain the mechanism aloud, identify the decisive cue, and state why the tempting alternative fails. Revisit pairs that are easy to confuse: midline versus PICC, phlebitis versus leakage, and TACO versus TRALI.

3. Work the original questions without cues

Complete all 20 questions before reading explanations. Classify each error as a knowledge gap, missed clinical cue, unit error, or unjustified assumption. Use the explanation to account for every alternative rather than memorizing the correct option.

4. Rehearse calculations and response sequences

Write units for rate calculations and compare order, concentration, and pump settings. Rehearse stopping delivery, obtaining help, retaining the device, and attempting aspiration without flushing for antineoplastic extravasation. Then add peripheral or central device management and the specific drug's thermal and antidote treatment.

5. Return to the outline and primary references

Use the flashcards for spaced recall, then study outline topics not developed here through the issuer's recommended resources. Practise sustained timed work with the 140-item, 150-minute format in mind, without interpreting a short drill score as a passing estimate.

Use your sample score as a starting point

The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.

Start the free sample

Official sources and updates

Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.